$8.510
+0.258 (+3.03%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ASBP Prediction & Forecast by Similar Chart Analysis
Alphio's ASBP stock price prediction model matches the current Aspire Biopharma Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.87 (+4.18%). The 1-week path is $8.76 (+2.98%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Aspire Biopharma Holdings Inc Stock?
PowerUp Acquisition Corp is not a good buy right now due to its significant decline in value, with a year-to-date change of -94.82% and a one-year change of -98.77%. Although the recent 5-day change is +6.78%, the overall trend remains negative, and the RSI is at 73.071, indicating potential overbought conditions. The main risk is its current financial instability, highlighted by a negative net income of -1,268,142 USD in Q2 2026 and a gross margin of -47.68%.
ASBP stock price ended at $8.51 on Friday, after rising +3.03%
Aspire Biopharma Holdings Inc (ASBP) last closed at $8.51, gaining +3.03%. These facts feed the 1-day and 1-week ASBP price prediction above.
Forecast Drivers
Aspire Biopharma Holdings Inc (ASBP) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ASBP, ranked by similarity.
Seasonality analysis for ASBP
Historically the probability of a positive August return for ASBP is 34.92%. November offers the highest probability of a positive month at 51.28%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ASBP
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $0.35 | $0.39 | $0.44 | -95.42% |
| Sep 2026 | $0.34 | $0.39 | $0.41 | -95.46% |
| Oct 2026 | $0.33 | $0.36 | $0.41 | -95.76% |
| Nov 2026 | $0.38 | $0.41 | $0.44 | -95.20% |
| Dec 2026 | $0.32 | $0.38 | $0.44 | -95.49% |
In 2026, Aspire Biopharma Holdings Inc (ASBP) is projected to range from $0.32 to $0.44.
Aspire Biopharma Holdings Inc 2026 monthly forecast
In Aug 2026, Aspire Biopharma Holdings Inc is projected to average $0.39, with a low of $0.35 and high of $0.44.
In Sep 2026, Aspire Biopharma Holdings Inc is projected to average $0.39, with a low of $0.34 and high of $0.41.
In Oct 2026, Aspire Biopharma Holdings Inc is projected to average $0.36, with a low of $0.33 and high of $0.41.
In Nov 2026, Aspire Biopharma Holdings Inc is projected to average $0.41, with a low of $0.38 and high of $0.44.
In Dec 2026, Aspire Biopharma Holdings Inc is projected to average $0.38, with a low of $0.32 and high of $0.44.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。